Re-examining the role of adjuvant radiation therapy.
Andrew J SpillaneAngela HongGerald FogartyPublished in: Journal of surgical oncology (2018)
Previously important roles for adjuvant radiotherapy (RT) in melanoma patients included improved regional control after resection of high-risk nodal disease, to reduce local recurrence for desmoplastic, and other subtypes of melanoma with neurotropism, reducing in-brain relapse of brain metastases after surgery and other situations on a case-by-case basis. This review evaluates the integration of adjuvant RT into clinical practice at this time of rapidly evolving knowledge and improving outcomes from effective systemic therapy.
Keyphrases
- early stage
- radiation therapy
- brain metastases
- end stage renal disease
- clinical practice
- small cell lung cancer
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- free survival
- prognostic factors
- locally advanced
- radiation induced
- lymph node
- stem cells
- skin cancer
- blood brain barrier
- mesenchymal stem cells
- smoking cessation
- rectal cancer
- cell therapy
- bone marrow